Analysed ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) News Sources
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18-06-2026
yahoo.com
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?
19-06-2026
yahoo.com
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
30-06-2026
yahoo.com
Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?
06-07-2026
yahoo.com
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
14-08-2026
yahoo.com
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
15-09-2026
yahoo.com
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
28-09-2026
yahoo.com
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
30-09-2026
yahoo.com
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
05-10-2026
yahoo.com
What is the current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is $0.99.
ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is $0.0081.
ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is 0.8249%.
What is the most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The most recent sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is .
SEC-8K** Filing Available For ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.